I didn't think
Release time:
2022-04-06
■ Retired Employee Xiang Shunjiao
"Unexpectedly" is my debut work published in "Peak Newspaper". It is written about me who joined Jinhua Pharmaceutical Company in 1985 . Unexpectedly, after more than 10 years, I became a colleague with my former playmate who worked in a cement factory. It also incidentally recalled the changes of Jinhua Pharmaceutical Company becoming a subsidiary of Jianfeng Group, as well as the development process of Jianfeng Group witnessed from my own growth experience. Unexpectedly, this article won the third prize in the essay competition for the 80th anniversary of the founding of the party. Since then, I have had a long-term contact with the "Peak News.
My own words will one day be turned into type in newspapers, which I never thought of when I could write. For the first time, I saw my signed article in the newspaper. Although it was only the size of dried tofu, my heart was still filled with a little excitement and pride. The publication of "Unexpected" gave me great confidence. I also began to pay attention to the big and small things in my life. I would record them from time to time. In the QQ space, which was very popular at that time, I graffiti some logs that were difficult to be elegant to amuse myself. Slowly, there are more and more records of my life and work in the space, "Talking about how to improve customer satisfaction in pharmacies", "My Father", "The Story of Five Bills", "The Story of Cars and Snakes" ...... Unexpectedly, these essays attracted the attention of Fu, the editor-in-chief of Spike News, and were selected to be published in Spike News.
When I pay attention to the things around me, I find that my life is so rich and colorful, and how interesting my pharmaceutical retail industry is. From the warm reception of customers who enter the store to the ability to calmly use their professional knowledge of drugs to reasonably guide customers to use drugs, every progress is so beautiful. Every time the customer's praise, can make me happy. I remember that in 2004 , I was the manager of Beiyuan drugstore in Jianfeng Pharmacy. At noon on a Sunday, our clerk received an order for 90 traditional Chinese medicine from a foreign customer. As the stock of traditional Chinese medicine stored in the drugstore was not large at that time, we needed to go to several drugstores to adjust. In order to complete it in time, everyone made concerted efforts to give up the rest. Without lunch, after more than two hours of division of labor and cooperation, the 90 post of traditional Chinese medicine was finally completed, so that the foreign customer could catch the train in time and return home smoothly. This incident was not only thanked by the customers, but also deeply moved me, so I wrote a short news story about it and wrote it to the "Peak News". I didn't expect that the "peak newspaper" not only published this article in time, but also recommended to participate in the "delixi cup " good news essay competition organized by the enterprise newspaper association. I didn't expect that the "90 post of traditional Chinese medicine" also won the second prize in the "delixi cup " good news competition. In many subsequent submissions, the most impressive one was 2014 , when Jianfeng Pharmacy and Ali Health took the lead in launching the sales model of BTC . The publication of this press release in Jianfeng Newspaper did not expect to attract the attention of securities companies, which in turn triggered small fluctuations in Jianfeng stocks.
With the continuous development of Jianfeng Pharmacy, I have also stepped onto the management position step by step. With heavy responsibilities, the pressure will naturally increase. In order to release the psychological pressure, I fell in love with Donkey Travel. Every weekend, I climb mountains and mountains with fellow travelers, challenge my endurance, exercise my teamwork ability to cooperate with everyone, and temper my will not be afraid of difficulties. In the donkey line, I experienced the beautiful scenery that ordinary people cannot enjoy, and also experienced the hardships that ordinary people cannot imagine. So I turned the meaningful donkey line into words under my keyboard and shared them with everyone. "Simple Walking, Happy Life " Pain and Happiness - My Donkey Line. I didn't expect that the "peak newspaper" would publish a special edition of my donkey line.
Unexpectedly, it has been 30 years since the publication of Peak Newspaper. Our peak has grown steadily in more "Unexpectedly " . Pu'er Peak, Huangping Peak, Anhui North Carolina, Yunnan Dazhan ... New peak enterprises have been built and developed rapidly, the big family of spike is breaking ground at the speed of "didn't expect " . these many "didn't expect " will be transmitted and spread to the hearts of spike people through "spike newspaper.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31